ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,32
-0,69%
Dow Jones
40 211,72
0,53%
DAX
18 493,85
-0,57%
Brent Oil
83,645
-0,82%
Bitcoin
62 762,84
-3,22%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intellia Therapeutics Inc (NTLA)

  7. Intellia Therapeutics Inc (NTLA) Actualités

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateHeureSourceTitreSymboleSociété
02/05/201913h30GlobeNewswire Inc.Intellia Therapeutics Announces First Quarter 2019 Financial Results and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
29/04/201913h30GlobeNewswire Inc.Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Societ...NASDAQ:NTLAIntellia Therapeutics Inc
25/04/201913h30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2019 Earnings and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
16/04/201922h32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NTLAIntellia Therapeutics Inc
15/04/201922h30GlobeNewswire Inc.Intellia Therapeutics Announces Three Oral Presentations on In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeti...NASDAQ:NTLAIntellia Therapeutics Inc
05/04/201923h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
25/03/201919h21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
12/03/201921h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
11/03/201920h18Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h41Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h39Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h00Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201912h30GlobeNewswire Inc.Intellia Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
14/02/201922h05Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:NTLAIntellia Therapeutics Inc
14/02/201917h34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NTLAIntellia Therapeutics Inc
24/01/201923h31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTLAIntellia Therapeutics Inc
24/01/201913h00GlobeNewswire Inc.Intellia Therapeutics Names Fred Cohen, M.D., to Board of DirectorsNASDAQ:NTLAIntellia Therapeutics Inc
20/12/201822h18Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:NTLAIntellia Therapeutics Inc
06/12/201813h30GlobeNewswire Inc.Intellia Therapeutics and Novartis Expand Cell Therapy Collaboration to Pursue CRISPR/Cas9-based Genome Editing in Additional...NASDAQ:NTLAIntellia Therapeutics Inc
08/11/201822h30GlobeNewswire Inc.Intellia Therapeutics to Present at November Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
31/10/201814h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
31/10/201812h30GlobeNewswire Inc.Intellia Therapeutics Announces Third Quarter 2018 Financial Results and Corporate DevelopmentsNASDAQ:NTLAIntellia Therapeutics Inc
30/10/201821h30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2018 Earnings and Corporate DevelopmentsNASDAQ:NTLAIntellia Therapeutics Inc
29/10/201821h30GlobeNewswire Inc.Intellia Therapeutics Names Glenn Goddard as New Chief Financial OfficerNASDAQ:NTLAIntellia Therapeutics Inc
18/10/201814h30GlobeNewswire Inc.Intellia Therapeutics Presents New Data in In Vivo and Ex Vivo Programs at the 26th Annual Congress of the European Society o...NASDAQ:NTLAIntellia Therapeutics Inc
12/10/201823h31Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:NTLAIntellia Therapeutics Inc
24/09/201814h30GlobeNewswire Inc.Intellia Therapeutics to Present at October Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
10/09/201822h30GlobeNewswire Inc.CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Provide Update on U.S Federal Circuit Decision Upholding t...NASDAQ:NTLAIntellia Therapeutics Inc
27/08/201814h00GlobeNewswire Inc.Intellia Therapeutics to Present at September Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA

Dernières Valeurs Consultées

NASDAQ
RXT
Rackspace Technology
LSE
FAN
Volution
BIT
P23OE8
NLBNPIT23OE8 20241220 1....
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés